A truly integrated drug discovery service: medicinal & computational chemistry, in vitro biosciences, DMPK, compound management and a diverse screening library.
Our customers choose BioAscent to cost-effectively and securely manage their compounds, connect their CRO network, and accelerate their design-make-test cycles.
Find out more: https://t.co/eHZrgt34zS
#DrugDiscovery#CompoundManagement
The @ELRIG_UK Protein Sciences in Drug Discovery meeting is underway at Hinxton Hall Conference Centre, Cambridgeshire.
If you would like to arrange a meeting with David, please get in touch: [email protected].
Find out more: https://t.co/FiFdWjejVF
#ProteinScience2024
Senior BioAscent scientists, Duncan McArthur and Angelo Pugliese, named as authors on recent paper: ‘Reversible small molecule pan-Ras inhibitors display tunable affinity for the active and inactive forms of Ras’.
Read the paper here: https://t.co/hCN5khXC61
#DrugDiscovery
Our computational chemists have years of knowledge and success applying multiple in silico ligand-based and structure-based methodologies at all stages of the drug discovery workflow.
Find out more: https://t.co/WDqKfzlHJZ
#CompChem#LigandModelling#ComputationalChemistry
The @ELRIG_UK Protein Sciences in Drug Discovery meeting begins next week.
If you would like to arrange a meeting, please get in touch by emailing [email protected].
Find out more about the meeting: https://t.co/RykHDVh7U2
#ProteinScience2024#IntegratedDrugDiscovery
BIO-Europe is underway in Stockholm, Sweden.
Business Development Director for Europe Michalina Lewicka-Yammine is attending and is available to answer questions about our services.
To arrange a meeting, get in touch: [email protected].
Find out more: https://t.co/kGlu4ahlux
We're pleased to announce the successful award of a Knowledge Transfer Partnership with the Centre for Targeted Protein Degradation at the School of Life Sciences, at the @dundeeuni.
The collaboration brings together BioAscent’s world-class pre-clinical drug discovery expertise with Dundee’s globally recognised leadership and experience in the field of targeted protein degradation.
BioAscent's Business Development Director for Europe Michalina Lewicka-Yammine had the pleasure of attending the @EBDgroup Bio-Europe reception last night ahead of the main event.
Find out more: https://t.co/yvV6Loe8NY
#BIOEurope#Event#Networking#IntegratedDrugDiscovery
Today, we're showing appreciation to our brilliant team with some special spooky-themed goody bags. Each treat is a small token of gratitude for their hard work and commitment.
Wishing everyone a happy Halloween.
#TeamAppreciation#EmployeeRecognition#IntegratedDrugDiscovery
Our state-of-the-art facility securely stores and manages customer libraries varying in size from tens of compounds, through to hundreds-of-thousands of compounds, in liquid and solid formats.
Find out more: https://t.co/eHZrgt34zS
#CompoundManagement#CompoundStorage
Bio-Europe begins next week in Stockholm.
Business Development Director for Europe Michalina Lewicka‑Yammine will be attending the event.
To arrange a meeting, email [email protected].
Find out more: https://t.co/yvV6Loe8NY
@EBDgroup#BIOEurope#IntegratedDrugDiscovery
We understand the importance of making the right compound, not any compound, and that delivering a successful molecule with the appropriate biological, ADME and safety profile is set at the design stage.
Learn more: https://t.co/jED6XmzhHC
#MedChem#AssayDevelopment
Today, BioAscent Senior Scientists Dominika Kowalczyk and Jonathan McKinstray are exhibiting at the @UofGlasgow STEM Fair, connecting with university students and discussing the exciting career opportunities available in drug discovery.
Our customers choose BioAscent to cost-effectively and securely manage their compounds, connect their CRO network, and accelerate their design-make-test cycles.
Discover more about our compound management expertise: https://t.co/eHZrgt34zS
#CompoundManagement#DrugDiscovery